Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cochlear implants recommended by National Institutes of Health (NIH)

This article was originally published in Clinica

Executive Summary

Describing cochlear implants as "unparalleled" in their ability to bring the sounds of the world to many who are deaf, a National Institutes of Health panel has recommended the device for adults with severe hearing loss who receive marginal benefit from hearing aids. NIH estimates this could allow nearly one million people with severe hearing impairment to understand speech. Only children and profoundly deaf adults currently receive the device, but more than 12,000 persons worldwide have been given the implant over the past 20 years.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT091761

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel